trial
as of 2026-07-01Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
NCTId NCT01164059
at a glance
Phase 4 · Completed
Enrollment 149 (actual)
Sponsored by University of Bremen
Primary completion 2013-08
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
149 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2010-02
Primary completion
2013-08
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
University of BremenLead Sponsor
Sites
18 total
Aachen, GermanyAngermünde, GermanyBad Zwischenahn, GermanyBerlin, GermanyBerlin, GermanyBochum, GermanyBremen, GermanyDüsseldorf, GermanyEisenhüttenstadt, GermanyGöttingen, GermanyHamburg, GermanyHanover, Germany
Facts & assertions
4 sourced
Enrollment
149
Phase
PHASE4
Primary Completion Date
2013-08
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
indication
indication